Skip to main content
Advertisement
Advertisement

LPCN

LPCN logo

Lipocine Inc.

2.24
USD
Sponsored
-0.08
-3.57%
Sep 22, 15:57 UTC -4
Closed
exchange

Pre-Market

2.20

-0.04
-1.79%

LPCN Earnings Reports

Positive Surprise Ratio

LPCN beat 29 of 43 last estimates.

67%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$162.69K
/
-$0.36
Implied change from Q2 26 (Revenue/ EPS)
-14.37%
/
+12.50%
Implied change from Q3 25 (Revenue/ EPS)
+41.47%
/
-38.98%

Lipocine Inc. earnings per share and revenue

On Aug 04, 2026, LPCN reported earnings of -0.32 USD per share (EPS) for Q2 26, beating the estimate of -0.44 USD, resulting in a 27.88% surprise. Revenue reached 190.00 thousand, compared to an expected 159.63 thousand, with a 19.03% difference. The market reacted with a +0.95% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.36 USD, with revenue projected to reach 162.69 thousand USD, implying an increase of 12.50% EPS, and decrease of -14.37% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
FAQ
For Q2 2026, Lipocine Inc. reported EPS of -$0.32, beating estimates by 27.88%, and revenue of $190.00K, 19.03% above expectations.
The stock price moved up 0.95%, changed from $2.11 before the earnings release to $2.13 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on 3 analysts, Lipocine Inc. is expected to report EPS of -$0.36 and revenue of $162.69K for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement